Montserrat Cuquerella

Montserrat Cuquerella

Auto-generated profile, based on publicly available information

Montserrat Cuquerella

Department of Animal Health, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
AOAna Isabel Olías-Molero
Ana Isabel Olías-Molero
CFConcepción de la Fuente
Concepción de la Fuente
MCMontserrat Cuquerella
Montserrat Cuquerella
JTJuan J. Torrado
Juan J. Torrado
José María AlundaJosé María Alunda
José María Alunda
Leishmaniasis is a vector-borne parasitic disease caused by Leishmania species. The disease affects humans and animals, particularly dogs, provoking cutaneous, mucocutaneous, or visceral processes depending on the Leishmania sp. and the host immune response. No vaccine for humans is available, and the control relies mainly on chemotherapy. However, currently used drugs are old, some are toxic, and the safer presentations are largely unaffordable by the most severely affected human populations. Moreover, its efficacy has shortcomings, and it has been challenged by the growing reports of resistance and therapeutic failure. This manuscript presents an overview of the currently used drugs, the prevailing model to develop new antileishmanial drugs and its low efficiency, and the impact of deconstruction of the drug pipeline on the high failure rate of potential drugs. To improve the predictive value of preclinical research in the chemotherapy of leishmaniasis, several proposals are presented to circumvent critical hurdles—namely, lack of common goals of collaborative research, particularly in public–private partnership; fragmented efforts; use of inadequate surrogate models, especially for in vivo trials; shortcomings of target product profile (TPP) guides.

1 March 2014 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
MCM. J. Corral
M. J. Corral
EGE. González-Sánchez
E. González-Sánchez
MCM. Cuquerella
M. Cuquerella
José María AlundaJosé María Alunda
José María Alunda
Current monotherapy against visceral leishmaniasis has serious side effects, and resistant Leishmania strains have been identified. Amphotericin B (AmB) has shown an extraordinary antileishmanial efficacy without emergence of resistance; however, toxicity has limited its general use. Results obtained showed, using a fixed-ratio analysis, that the combination of diallyl thiosulfinate (allicin) and AmB ranged from moderately synergic to synergic at low concentrations (0.07 μM AmB plus 35.45 μM allicin induced 95% growth inhibition). None of the treatments, alone or in combination, had noticeable adverse effects on macrophages (Mϕ) in the concentration range examined (allicin, 0.5, 1, 5 and 10 μM; AmB, 0.05, 0.075, and 0.1 μM). Allicin, AmB, or the combination did not affect the infection rate (percentage of infected Mϕ) of Leishmania . Allicin enhanced the activity of AmB on intracellular amastigotes of Leishmania donovani and L. infantum (ca. 45% reduction of amastigote burden with 0.05 μM AmB plus 10 μM allicin); this represented nearly a 2-fold reduction in the 50% inhibitory concentration (IC 50 ) of the antibiotic added alone. Results point toward the possible utility of testing this combination in vivo to reduce the toxicity associated with monotherapy with AmB.

1 March 1996 in Experimental Parasitology
Verified
Journal Article
Closed access
LCLucı́a Carrera
Lucı́a Carrera
MFM.Luisa Fermı́n
M.Luisa Fermı́n
MTMiguel Tesouro
Miguel Tesouro
PGPilar Garcı́a
Pilar Garcı́a
EREduardo Rollán
Eduardo Rollán
José María AlundaJosé María Alunda
José María Alunda

1 August 2013 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
MCMaría Jesús Corral
María Jesús Corral
EGElena González
Elena González
MCMontserrat Cuquerella
Montserrat Cuquerella
José María AlundaJosé María Alunda
José María Alunda

15 March 1999 in Veterinary Parasitology
Verified
Journal Article
Closed access
María Teresa GómezMaría Teresa Gómez
María Teresa Gómez
MCM Cuquerella
M Cuquerella
LGL.A Gómez-Iglesias
L.A Gómez-Iglesias
SMS Méndez
S Méndez
FFF.J Fernández-Pérez
F.J Fernández-Pérez
José María AlundaJosé María Alunda
José María Alunda